Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute for Genomic Statistics and Bioinformatics, |
RCV001171512 | SCV001245456 | likely pathogenic | Rett syndrome, congenital variant | 2020-04-20 | criteria provided, single submitter | clinical testing | The variant c.759C> A; p.(Asn253Lys) in the FOXG1 gene (transcript: NM_005249.4) is not listed in population-related databases (gnomAD, 1OOOGenomes and Exome Variant Server). It is also not listed in the phenotype-related databases HGMD, ClinVar and LOVD. However, the variant c.757A> G; p.(Asn253Asp), which affects the same amino acid, has already been described as pathogenic (see PMID: 21441262). The mutation prediction programs MutationTaster, Polyphen, SIFT and PROVEAN rate the variant as pathogenic, the CADD score is 27.6. The in silica analysis using the Alamut software does not provide any clear indication of a change in splicing behavior with various prediction programs, only the Human Splicing Finder program predicts the generation of a new donor splicing site. The FOXG1 variant was also detected in the patient's brother, who was also affected. The mother was found in one of 132 reads of the sequencing data. Overall, the FOXG1 variant is probably considered pathogenic (PM1, PM2, PM5, PP2, PP3). |